China Shineway Pharmaceutical Group Ltd ADR (CSWYY)
Company Info
Highlights
$727.07M
$3.08
6.25
$289.19M
$217.88M
$131.05M
$17.54 - $21.59
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
CSWYY
N/A
9.76%
N/A
N/A
N/A
N/A
N/A
^GSPC (Benchmark)
0.52%
6.32%
-1.44%
12.25%
12.45%
14.20%
10.84%
Monthly Returns
The table below presents the monthly returns of CSWYY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 1.44% | -18.75% | 9.76% | -9.54% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CSWYY is 15, meaning it’s performing worse than 85% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for China Shineway Pharmaceutical Group Ltd ADR (CSWYY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
China Shineway Pharmaceutical Group Ltd ADR provided a 6.70% dividend yield over the last twelve months, with an annual payout of $1.29 per share. The company has been increasing its dividends for 2 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.29 | $1.49 | $1.20 | $0.98 | $1.85 | $0.66 | $0.67 | $0.70 | $0.59 | $0.94 | $0.73 | $0.65 |
Dividend yield | 6.70% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Monthly Dividends
The table displays the monthly dividend distributions for China Shineway Pharmaceutical Group Ltd ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.98 | $0.98 | ||||||||
| 2024 | $1.18 | $0.31 | $1.49 | ||||||||||
| 2023 | $0.90 | $0.30 | $1.20 | ||||||||||
| 2022 | $0.66 | $0.32 | $0.98 | ||||||||||
| 2021 | $0.64 | $1.21 | $1.85 | ||||||||||
| 2020 | $0.34 | $0.32 | $0.66 | ||||||||||
| 2019 | $0.36 | $0.31 | $0.67 | ||||||||||
| 2018 | $0.38 | $0.32 | $0.70 | ||||||||||
| 2017 | $0.25 | $0.33 | $0.59 | ||||||||||
| 2016 | $0.61 | $0.33 | $0.94 | ||||||||||
| 2015 | $0.39 | $0.34 | $0.73 | ||||||||||
| 2014 | $0.32 | $0.32 | $0.65 |
Dividend Yield & Payout
Dividend Yield
China Shineway Pharmaceutical Group Ltd ADR has a dividend yield of 6.70%, which means its dividend payment is significantly above the market average.
Payout Ratio
China Shineway Pharmaceutical Group Ltd ADR has a payout ratio of 48.19%, which is quite average when compared to the overall market. This suggests that China Shineway Pharmaceutical Group Ltd ADR strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the China Shineway Pharmaceutical Group Ltd ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the China Shineway Pharmaceutical Group Ltd ADR was 18.75%, occurring on Apr 29, 2025. The portfolio has not yet recovered.
The current China Shineway Pharmaceutical Group Ltd ADR drawdown is 10.82%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -18.75% | Apr 29, 2025 | 1 | Apr 29, 2025 | — | — | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of China Shineway Pharmaceutical Group Ltd ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how China Shineway Pharmaceutical Group Ltd ADR is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CSWYY, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CSWYY has a P/E ratio of 6.3. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CSWYY relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CSWYY has a P/S ratio of 0.2. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CSWYY in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CSWYY has a P/B value of 0.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |